bluuebunny/crossref_metadata_2025_split huggingface dataset:
Evaluation of automated urinary iodine methods: problems of interfering substances identified
Authors: May W , Wu D , Eastman C , Bourdoux P , Maberly G 
Published: January 2020

Abstract
We evaluated automated methods for measurement of urinary iodine (UI) over a range expected in iodine-replete and iodine-deficient populations. Results obtained with Technicon AutoAnalyzer II systems, based on either dialysis or acid digestion, were compared with those obtained by a manual alkaline ashing technique. Results of automated dialysis were consistently higher than those obtained by the other methods. The apparently higher concentrations of UI we measured were due to interfering substances crossing the dialysis membrane and participating in the catalytic reaction. Thiocyanate (SCN) was one endogenous substance contributing to the increased measurement of UI. For urinary SCN concentrations of 5 to 15 mg/L, the amount of overestimation in the UI measurement attributable to SCN ranged from 21.8 to 61 micrograms/L. However, SCN may account for only 40-50% of the apparent increase in UI. In samples with lower UI (less than 50 micrograms/L), interfering substances produced a 100% error in results. We conclude that the automated dialysis system should not be used to assess iodine-deficient populations. This leaves a major dilemma for researchers wanting to assess the iodine status of populations, because the automated digestion method is no longer commercially available.
Interference by human anti-mouse antibody in two-site immunoassays
Authors: Kricka L J , Schmerfeld-Pruss D , Senior M , Goodman D B , Kaladas P 
Published: January 2020

Abstract
Studies with goat and rabbit anti-mouse antibody, as models of human anti-mouse antibody (HAMA), have shown that several of the commonly used two -site immunoassays (e.g., for CA-125, carcinoembryonic antigen, choriogonadotropin, lutropin, hepatitis B surface antigen, thyrotropin) are susceptible to interference by this type of bridging heterophile antibody. In most cases the interference can be blocked by incubation with mouse IgG. We studied HAMA interference in an assay of hepatitis B surface antigen by using HAMA-positive sera from a transplant patient given OKT3 and from a cancer patient given CYT-103 (modified antibody B72.3). The HAMA interference attributable to the OKT3 could be blocked by incubation with mouse IgG at room temperature. In contrast, the interference caused by the B72.3-induced HAMA could be blocked by prolonged incubation with high concentrations of the B72.3 antibody at 4 degrees C. A limited survey of 50 hospital patients selected without conscious bias revealed two HAMA-positive patients, only one of whom was known to have been exposed to mouse immunoglobulin. HAMA interferences are currently a minor problem in routine laboratory medicine, but the increasing use of diagnostic and therapeutic products involving mouse-origin monoclonal antibodies will make the detection and elimination of HAMA interferences an important part of laboratory practice in the future.
Convenient screening for hemoglobin variants by using the Diamat HPLC system
Authors: Delahunty T 
Published: January 2020

Abstract
Hemolysates from 102 different patients previously assessed for the presence of hemoglobin variants by cellulose acetate electrophoresis were reanalyzed with the Diamat, a microprocessor-controlled step-gradient HPLC technique designed to determine glycohemoglobin (Hgb A1c). This pool contained 81 abnormal specimens, each with one of seven different variant abnormalities. In all cases the HPLC technique correctly detected the presence or absence of a variant. The common S trait gave a large peak immediately after Hgb A, and the SS and SC variants gave clearly abnormal patterns, caused in part by the absence of Hgb A. The pattern from EE variants was distinguished by the appearance of the glycated fraction Hgb E1c, which is eluted at 4.7 instead of 4.2 min, whereas the AE pattern had two glycated peaks. Hemoglobins F, "fast", S, and C were discerned by the presence of a major peak at 3, 5.2, 6.5, and 7.5 min, respectively. The findings suggest that the Diamat is a convenient tool to detect and help diagnose variants in a screening pool.
Effects of recombinant leukocyte interferon on ribonuclease activities in serum in chronic hepatitis B
Authors: Tsuji H , Murai K , Akagi K , Fujishima M 
Published: January 2020

Abstract
Alkaline ribonuclease (RNase; EC 3.1.27.5) activities and 2',5'-oligoadenylate synthetase (2-5 AS; no EC no. assigned) activities in serum were measured in nine patients with hepatitis B e antigen-positive chronic hepatitis B before, during, and after treatment with recombinant human interferon alpha-2b for four weeks at daily doses ranging from 3 to 10 mega-units. Alkaline RNase activities in serum significantly increased from 65.8 +/- 9.5 units/L (mean +/- SD) to 84.3 +/- 11.9 units/L after the first week of therapy (P less than 0.001). (One unit of RNase activity is defined as that increasing the absorbance at 260 nm by 1.0 in 1 min). This increase persisted during and until two weeks after the end of the therapy, at which time the mean RNase activity in serum was still significantly increased (70.8 +/- 9.4 units/L, P less than 0.01). Before therapy, phosphocellulose chromatography of RNase showed five active peaks of enzyme activity, which were similar to that observed even when RNase activity increased immediately after therapy. There was a close correlation between RNase activities and the logarithm of 2-5 AS activities, measured simultaneously in each patient. We conclude that recombinant alpha-interferon therapy increases RNase activities in serum, associated with the increased 2-5 AS activities.
Reference values of magnesium and potassium in mononuclear cells and erythrocytes of children
Authors: Geven W B , Vogels-Mentink G M , Willems J L , de Boo T , Lemmens W , Monnens L A 
Published: January 2020

Abstract
Reference values for magnesium and potassium contents of mononuclear cells and erythrocytes were estimated in cord blood and in children from infancy through adolescence. No differences were detected between results for boys and girls. The mononuclear magnesium content was independent of age and was within the adult range of values. No significant correlation was shown between magnesium in serum and in mononuclear cells. Mononuclear potassium also showed no age-related differences. The correlation between magnesium and potassium contents in mononuclear cells was significant: however, the correlation was lower when the magnesium and potassium contents were expressed in terms of protein potent: micromoles or millimoles per gram of protein, respectively. The concentration of magnesium in erythrocytes was significantly lower in cord blood and during the first month of life, compared with that at older ages, and showed no significant correlation with serum magnesium. The concentration of erythrocyte potassium was independent of age and showed a low but significant correlation with erythrocyte magnesium content.
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
Authors: Melkko J , Niemi S , Risteli L , Risteli J 
Published: January 2020

Abstract
Type I collagen is the most abundant collagen type in soft tissues and the only type found in mineralized bone. We established a rapid equilibrium radioimmunoassay for the carboxyterminal propeptide of human type I procollagen (PICP), to be used as an indicator of the synthesis of type I collagen. We isolated type I procollagen from the medium of primary cultures of human skin fibroblasts, digested the protein with highly purified bacterial collagenase, and purified PICP by lectin-affinity chromatography, gel filtration, and ion-exchange separation on HPLC. The purity of the protein was verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by N-terminal amino acid sequencing of its component chains. The final radioimmunoassay was established with polyclonal rabbit antibodies. Material antigenically related to PICP is readily detected in human serum. There is only one form of the serum antigen, its molecular size and affinity to the antibodies being similar to those of the isolated propeptide. Intra- and interassay CVs are 3% and 5%, respectively. Preliminary reference intervals for healthy adults (18 to 61 years of age) are 38-202 micrograms/L for men and 50-170 micrograms/L for women: in men the concentration is inversely related to age. The serum antigen is stable during storage and after repeated thawing.
Use and abuse of imprecision profiles: some pitfalls illustrated by computing and plotting confidence intervals
Authors: Sadler W A , Smith M H 
Published: January 2020

Abstract
Published estimates of the imprecision characteristics of immunoassays are often based on quantities of data that seem to be inadequate. The increasing use of imprecision profiles has not necessarily improved the situation. We describe and illustrate a method of computing 95% confidence intervals for profiles estimated directly from replicated assay results. The data used were chosen to mimic the sort of data that are typically available in practice, either within laboratories or from external quality-assessment programs. Use of confidence intervals is an effective pictorial way of incorporating information about the quantity and the distribution of the data used for estimation. This is in keeping with an important property of imprecision profile plots: potentially complex information is summarized in a readily comprehensible way. A computer program is available for estimating and plotting profiles and their 95% confidence intervals.
Factors affecting the concentrations of ferritin in serum in a healthy Australian population
Authors: Leggett B A , Brown N N , Bryant S J , Duplock L , Powell L W , Halliday J W 
Published: January 2020

Abstract
We measured by different techniques the ferritin concentration in serum in two large asymptomatic Australian population samples: 1367 bank employees and 601 insurance corporation employees. Ethanol intake, diet, the frequency of blood donation, smoking and exercise habits, and past medical history were documented. The median concentration of ferritin in serum varied according to age and sex, but was generally higher than in previously reported populations under age 65 years. Results for the two population samples were in close agreement. Apart from the blood donation status, the most important factors influencing the concentration of ferritin in serum were ethanol intake in men and diet in women. Heavy ethanol intake was associated with increased values, even among men without evidence of liver disease. We conclude that the reference range for ferritin concentration in serum in the Australian population should be significantly increased and should be related to age as well as sex. This study emphasizes the need to determine local reference ranges for ferritin concentrations in serum.
Effects of storage time and temperature on measurement of small concentrations of albumin in urine
Authors: Osberg I , Chase H P , Garg S K , DeAndrea A , Harris S , Hamilton R , Marshall G 
Published: January 2020

Abstract
Accurate measurement of albumin excretion rates is important in choosing treatment regimens that may reverse early diabetic renal damage. We report here determinations of slight albuminuria ("microalbuminuria") by radioimmunoassay of fresh specimens, frozen aliquots (stored at -20 degrees C for two, eight, and 24 weeks), and refrigerated specimens (stored at 4 degrees C for one, two, and eight weeks). Seven separate analyses were performed on 101 specimens of urine obtained from 37 subjects with insulin-dependent diabetes mellitus and from 10 nondiabetic healthy controls of a similar age. Storage of urine samples at -20 degrees C resulted in significantly lower measurements of microalbuminuria than in fresh urine (ANOVA, corrected for repeated measures: P = 0.01 to 0.0001). In contrast, storage of urine samples at 4 degrees C for as long as eight weeks did not significantly affect urinary albumin results. The pH values of the specimens were minimally altered and were not a likely cause of the decreased albumin values in the frozen specimens. We conclude that urine specimens for microalbuminuria measurements should either be analyzed as fresh specimens or stored at 4 degrees C and assayed as soon as possible.
Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent
Authors: Christenson R H , Clemmensen P , Ohman E M , Toffaletti J , Silverman L M , Grande P , Vollmer R T , Wagner G S 
Published: January 2020

Abstract
We compared relative increases in creatine kinase (EC 2.7.3.2) MB isoenzyme (CK-MB) after reperfusion in myocardial infarction for four popular methods: electrophoresis, immunoinhibition, the "Magic Lite" (Ciba-Corning) system, and the Stratus (Dade). In a method comparison study, we confirmed that all four methods correlated (r greater than 0.95). Electrophoresis demonstrated the greatest scatter about the regression line, immunoinhibition the least. For CK-MB quantities near each method's "positive cutoff" indicating myocardial infarction, results by all methods agreed in 95% of samples. To characterize relative increases in CK-MB, we computer-fitted data obtained from each method for serial specimens collected from six acute myocardial infarction patients during myocardial reperfusion. Although for each individual patient the four methods appeared to exhibit parallelism, the methods differed significantly in terms describing their appearance rate, peak-time & fall-off, and time-to-peak activity. Consistent with these data, we found that the relative CK-MB increases at various times after reperfusion, compared with baseline concentrations, are method-dependent. Therefore, when using CK-MB for indicating coronary patency, one must develop specific limits for each method utilized.
Silicon measurement in serum and urine by direct current plasma emission spectrometry
Authors: Roberts N B , Williams P 
Published: January 2020

Abstract
Elemental silicon, present as soluble silicic acid in serum and urine, has been measured by direct current plasma emission spectrometry. The method is precise and accurate, yields a standard curve that is linear up to 1000 mumol/L, and requires only a simple dilution in 10 mL/L HNO3. No spectral or background interferences have been observed from serum or urine; the absolute detection limit for silicon was 0.5 mumol/L. Silicon concentrations in serum increase by up to 20-fold in patients with chronic renal failure on hemodialysis, an increase apparently related to dietary silicon intake. No relationship with aluminum was observed in hemodialysis patients, with or without aluminum toxicity. In the undialyzed patient with chronic renal failure, the concentrations of silicon in plasma increased with decreasing glomerular filtration rate. This increase may protect renal-failure patients from possible aluminum toxicity by promoting formation of the relatively inactive aluminosilicate complex. Silicon concentrations in urine of healthy individuals exceed their serum concentrations by 20- to 100-fold. Silicon excretion in patients with renal stones was not different from that in healthy controls and showed no relationship with calcium and (or) oxalate excretion.
Bromide interference: is less really better?
Authors: Emancipator K , Kroll M H 
Published: January 2020

Abstract
Increased serum bromide may result from the ingestion of various drugs and from environmental exposures. Chloride methods that are less susceptible to bromide interference have a clinical disadvantage in that they are less likely to arouse suspicion in cases of bromide toxicity. When there is a clinical suspicion of bromide toxicity, differences among various analyzers in the amount of interference caused by bromide may be exploited to confirm this suspicion and to estimate the concentration of bromide in serum.
Determination of free progesterone in an ultrafiltrate of saliva collected in situ
Authors: Schramm W , Smith R H , Craig P A , Paek S H , Kuo H H 
Published: January 2020

Abstract
We have investigated the utility of an ultrafiltrate of saliva for measuring progesterone as an indicator of luteal function during the menstrual cycle of women. A filtrate of saliva is collected in the mouth by means of an osmotic pump that accumulates medium containing only molecules less than 12,000 Da. We analyzed the nonextracted ultrafiltrate by a solid-phase immunoassay for progesterone and monitored the mid-luteal surge of lutropin in urine with a liquid-phase radioimmunoassay. Progesterone concentrations in the ultrafiltrate are significantly lower during the follicular phase and increase after the release of lutropin. The concentration of progesterone in the ultrafiltrate correlates closely with total progesterone in matched blood samples (r = 0.84, cycle 1; and r = 0.89, cycle 2). Likewise, we found a good correlation between the results in whole saliva and in the ultrafiltrate (r = 0.95). The described method of obtaining a pre-processed specimen noninvasively simplifies the self-collection of samples by patients (including collection at home); excludes potential interference from microorganisms, desquamated cells, and salivary components; and simplifies the processing of the biological fluid in the laboratory.
Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB
Authors: Jørgensen P J , Hørder M , Selmer J , Bøtker H E 
Published: January 2020

Abstract
We have evaluated a new sensitive immunometric assay for the determination of creatine kinase (CK; EC 2.7.3.2) MB isoenzyme (NovoClone CK-MB), involving an enzyme label and two monoclonal antibodies directed against the B subunit and the M subunit, respectively. The anti-CK-B antibodies are bound to the solid phase. The assay was modified to be extremely sensitive and thus to measure the concentration range below and close to the cutoff value used for the diagnosis of myocardial infarction. A reference interval of 0-6 micrograms/L was found for 315 outpatients without myocardial diseases (132 men and 183 women); the overall median of the log-gaussian distribution was 1.91 micrograms/L (2.03 and 1.79 micrograms/L for men and women, respectively). Total and within-assay imprecision (CV) was less than 6% at the upper reference limit. The detection limit was 0.1 microgram/L. The assay provides a favorable signal-to-noise ratio: the calibrators 0.0, 2.0, and 30.0 micrograms/L give absorbances at 492 nm of 0.040, 0.140, and 1.600 A. respectively. We conclude that the assay provides biochemical identification of individuals with myocardial damage but without myocardial infarction.
Continuous ex vivo and in vivo monitoring with chemical sensors
Authors: Fogt E J 
Published: January 2020

Abstract
The chemical species of principal clinical interest for continuous monitoring include oxygen, carbon dioxide, pH, potassium, and glucose. Although sensors exist for all of these analytes, relatively few continuous monitors are used for blood chemistries. Reviewing the available electrochemical and optical approaches along with the expected system performance requirements provides some insight into the reasons for this. In particular, the performance of sensor systems is significantly dependent on the environment in which they are used: transcutaneous, intravascular, intramuscular, etc. The future success and acceptance of "real-time" continuous monitoring of the critically ill patient probably does not require the development of new sensors for additional species. Rather, improvements in the stability of existing devices and protection of the sensor's chemistry from the environment are needed. Eventually, the development of new sensing technologies, e.g., near infrared spectroscopy, may lead to a completely noninvasive system capable of monitoring a broad spectrum of analytes.
Other aspects of metabolic monitoring in critically ill patients
Authors: Konstantinides F N , Kaproth P L , Cerra F B 
Published: January 2020

Abstract
Cardiopulmonary monitoring remains the mainstay of intensive-care unit utilization of clinical chemistry resources. Its focus has been on the restoration and maintenance of oxygen transport. Metabolic monitoring, a relatively new area of application for clinical chemistry technology, focuses on cell metabolism and on cell-cell interaction as a mechanism of metabolic regulation. This latter application of monitoring is developing as a result of a better understanding of the pathogenesis of organ dysfunction and disease processes in intensive-care unit patients. Some of the clinical chemistry technologies used include analyses for amino acids and polyunsaturated fatty acids, measurement of cytokine concentration and activity, nutritional assessment and monitoring, more sensitive monitors of liver function, and assessment of altered immunity in critically ill patients. Use of these technologies, along with specific support measures, offers new avenues for decreasing infectious complications and reducing mortality and morbidity of patients in intensive-care units.
How can new technology be introduced, evaluated, and financed in critical care?
Authors: Sibbald W J , Escaf M , Calvin J E 
Published: January 2020

Abstract
We briefly review issues impacting the introduction, evaluation, and cost of technology in critical care, providing a clinician's perspective. Where appropriate, we note important distinctions between health-care systems in Canada and the United States--primarily the result of significant differences in the methods for funding health care in the two countries. Finally, we discuss what processes might be reasonably considered for evaluating technology in critical care and discuss the probability of various consequences that will significantly affect the care we provide our patients if critical-care practitioners, industry, and health planners fail to jointly undertake this responsibility.
A systematic approach to materials handling in clinical laboratories
Authors: Nabb D P 
Published: January 2020

Abstract
I describe the automation/mechanization of several areas of sample processing at SmithKline Beecham Clinical Laboratories. By analyzing and implementing new systems for conveyance and sorting of incoming specimens, specimen processing, within-laboratory specimen delivery, specimen storage and retrieval, and client resupply, we greatly improved the productivity of the nontechnical aspects of laboratory operations.
Application of existing technology to meet increasing demands for automated sample handling
Authors: Chow A T , Kegelman J E , Kohli C , McCabe D D , Moore J F 
Published: January 2020

Abstract
As the clinical laboratory advances toward total automation, the marketplace is now demanding more-efficient sample-handling systems. These demands have arisen over a relatively short period of time, in part because of heightened concern over laboratory safety and the resulting manpower shortages. Adding sample-handling capabilities to existing instrumentation is often a challenge, because usually mechanical or system constraints are present that interfere. This challenge has been overcome in the DuPont Sample Management System (SMS), a second-generation general chemistry analyzer that incorporates the latest barcode and computer-interfacing technology. The development of the SMS system relies heavily on recent advances in technology, e.g., software modeling and computer-aided design. The SMS system includes a barcode scanner based on "charge-coupled device" technology, a random-access sample wheel, and new software that oversees the various functions.